510(k) K200661
K200661 is an FDA 510(k) premarket notification submitted by Magnolia Medical Technologies, Inc. for the device "Steripath Micro Blood Collection System". The FDA issued a decision of Substantially Equivalent on October 8, 2020. The device falls under product code FPA (Set, Administration, Intravascular), a Class II device regulated under 21 CFR 880.5440. Magnolia Medical Technologies, Inc. has at least 3 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- October 8, 2020
- Date Received
- March 12, 2020
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Set, Administration, Intravascular
- Device Class
- Class II
- Regulation Number
- 880.5440
- Review Panel
- HO
- Submission Type